Emergent BioSolutions Inc.
EBSNYSESmall CapHealthcare
13F Pro Quality Score
31.2/100
Rank #2,463 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
4.1/100
Profitability
14.0/100
Balance Sheet
14.3/100
Earnings Quality
56.2/100
Free Cash Flow
57.9/100
Institutional Flow
66.6/100
Revenue Scale
45.1/100
Dilution Risk
38.7/100
Price Chart
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)
Key Metrics
Top Institutional Holders
as of Q2 2026$39.53M+8.6%
$25.78M+11.6%
$24.56M+2.8%
$23.22M+14.2%
$18.43M-2.6%
$14.21M+89.1%
$11.26M-2.7%
$11.21M+5.1%
$10.06M-20.3%
$9.33M0.0%
Financial Trends
Revenue & Net Income
Earnings Per Share
Loading ratio trend…